Climb Bio Statistics
NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.71+0.03 (+0.28%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Climb Bio by the numbers
Climb Bio has a market capitalization of $615.1 million based on 57.44M shares outstanding. With trailing EPS of $-0.82, Climb Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.4% below its 50-day average and 8.8% above its 200-day average.
Average daily trading volume is 1.39M shares, or about $14.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLYM valuation vs. peer median
| Metric | CLYM | Peer median | Difference |
|---|---|---|---|
| Market cap | $615.14M | $624.66M | -2% |
| Avg. volume | 1.39M | 1.18M | +17% |
Peer median across 8 companies: SLN, IRWD, SGMT, FTH, AQST, EVO, ABUS, ZVRA.
Valuation
- Market cap
- $615.14M
- EPS (TTM)
- $-0.82
- Shares outstanding
- 57.44M
Price and trading
- Previous close
- 10.68
- Open
- 10.43
- Day range
- 10.34 – 10.95
- 52-week range
- 1.64 – 18.33
- 52-week change
- +549.09%
- Beta
- —
- Volume
- 755.81K
- Average volume
- 1.39M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 615.14M
- Forward Pe
- -10.68
- Eps
- -0.82
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.33
- Week52 Low
- 1.64
- Avg Volume
- 1.39M
- Shares Outstanding
- 57.44M
- Ma50
- 13.99
- Ma200
- 9.84
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -41.57%
- Pct From52w Low
- 555.05%